CLOV - Clover Health Investments, Corp.
NASDAQ
->
Healthcare
->
Healthcare Plans
Franklin,
United States
Type: Equity
CLOV price evolution
CLOV
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 1 May 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $254.77 | $208.25 | $122.86 | |
| Short term investments | $124.28 | $134.1 | $119.82 | |
| Net receivables | $52.28 | $87.97 | $106.4 | $91.76 |
| Inventory | ||||
| Total current assets | $432.73 | $549.58 | $552.74 | $427.97 |
| Long term investments | $103.76 | $97.92 | $121 | |
| Property, plant & equipment | $7.92 | $8.13 | $8.33 | $8.46 |
| Goodwill & intangible assets | $2.99 | $2.99 | $2.99 | |
| Total noncurrent assets | $124.63 | $119.03 | $142.7 | |
| Total investments | $228.04 | $232.02 | $240.82 | |
| Total assets | $653.01 | $674.21 | $671.77 | $570.67 |
| Current liabilities | ||||
| Accounts payable | $25.75 | $240.99 | $35.41 | $218.71 |
| Deferred revenue | $0.01 | $3.1 | ||
| Short long term debt | $1.49 | $1.62 | $1.67 | |
| Total current liabilities | $279.63 | $324.51 | $356.39 | $261.12 |
| Long term debt | $2.52 | $2.72 | $3 | |
| Total noncurrent liabilities | $24.81 | $22.91 | $23.16 | |
| Total debt | $4.01 | $4.34 | $4.66 | |
| Total liabilities | $310.85 | $349.32 | $379.3 | $284.28 |
| Shareholders' equity | ||||
| Retained earnings | -$2180.71 | -$2171.56 | -$2178.96 | -$2159.79 |
| Other shareholder equity | $0.85 | -$2.26 | -$2.56 | -$2.37 |
| Total shareholder equity | $324.89 | $292.47 | $286.39 | |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $122.86 | $103.79 | $299.97 | $92.35 |
| Short term investments | $119.82 | $230.97 | $315.29 | $4.36 |
| Net receivables | $91.76 | $147.16 | $62.32 | $50.11 |
| Inventory | ||||
| Total current assets | $427.97 | $625 | $752.55 | $189.78 |
| Long term investments | $121 | $138.11 | $175.94 | $54.39 |
| Property, plant & equipment | $8.46 | $9.78 | $7.65 | $9.96 |
| Goodwill & intangible assets | $2.99 | $20 | $4.23 | $4.23 |
| Total noncurrent assets | $142.7 | $183.62 | $198.26 | $77.47 |
| Total investments | $240.82 | $369.08 | $491.23 | $58.76 |
| Total assets | $570.67 | $808.62 | $950.8 | $267.25 |
| Current liabilities | ||||
| Accounts payable | $218.71 | $32.45 | $206.83 | $134.65 |
| Deferred revenue | $3.1 | |||
| Short long term debt | $1.67 | $1.83 | $3.06 | $25.6 |
| Total current liabilities | $261.12 | $440.66 | $372.62 | $164.23 |
| Long term debt | $3 | $4.03 | $24.77 | $112.76 |
| Total noncurrent liabilities | $23.16 | $20.23 | $38.86 | $268.47 |
| Total debt | $4.66 | $5.86 | $27.83 | $138.36 |
| Total liabilities | $284.28 | $460.88 | $411.49 | $432.7 |
| Shareholders' equity | ||||
| Retained earnings | -$2159.79 | -$1955.58 | -$1616.74 | -$1028.98 |
| Other shareholder equity | -$2.37 | -$9.37 | -$1.93 | $0.01 |
| Total shareholder equity | $286.39 | $347.74 | $535.41 | -$617.1 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $356.26 | $346.92 | $510.25 | |
| Cost of revenue | $248.35 | $265.16 | $447.3 | |
| Gross Profit | $107.91 | $81.76 | $62.95 | |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $99.92 | $103.79 | $109.93 | |
| Total operating expenses | $100.73 | $104.46 | $128.61 | |
| Operating income | $7.19 | -$22.7 | -$65.66 | |
| Income from continuing operations | ||||
| EBIT | $7.41 | -$19.17 | -$70.47 | |
| Income tax expense | ||||
| Interest expense | ||||
| Net income | ||||
| Net income | $7.41 | -$19.17 | -$70.47 | |
| Income (for common shares) | $7.41 | -$19.17 | -$70.47 | |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $2033.72 | $3476.69 | $1472 | $672.89 |
| Cost of revenue | $1769.15 | $3359.71 | $1661.81 | $573.34 |
| Gross Profit | $264.57 | $116.97 | -$189.81 | $99.55 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $444.73 | $486.64 | $445.75 | $191.7 |
| Total operating expenses | $473.11 | $487.9 | $447.18 | $192.25 |
| Operating income | -$208.54 | -$370.92 | -$636.99 | -$92.71 |
| Income from continuing operations | ||||
| EBIT | -$213.35 | -$337.51 | -$584.53 | -$100.4 |
| Income tax expense | ||||
| Interest expense | $0.01 | $1.33 | $3.23 | $35.99 |
| Net income | ||||
| Net income | -$213.36 | -$338.84 | -$587.76 | -$136.39 |
| Income (for common shares) | -$213.36 | -$338.84 | -$587.76 | -$136.39 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Net income | $7.41 | -$19.17 | -$70.47 | |
| Operating activities | ||||
| Depreciation | $0.33 | $0.32 | $0.67 | |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $27.9 | $28.8 | $33.14 | |
| Total cash flows from operations | $44.76 | $25.93 | -$229.29 | |
| Investing activities | ||||
| Capital expenditures | -$0.4 | -$0.45 | $0.26 | |
| Investments | $5.35 | $9.63 | $83.4 | |
| Total cash flows from investing | $2 | $4.95 | $9.19 | $83.66 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | -$3.19 | -$3.36 | -$0.83 | |
| Net borrowings | ||||
| Total cash flows from financing | -$11.22 | -$3.19 | -$3.36 | -$29.62 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | $111.46 | $46.52 | $31.76 | -$175.25 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$213.36 | -$338.84 | -$587.76 | -$136.39 |
| Operating activities | ||||
| Depreciation | $2.51 | $1.19 | $1.25 | $0.56 |
| Business acquisitions & disposals | -$16.45 | |||
| Stock-based compensation | $140.93 | $164.31 | $163.72 | $7.08 |
| Total cash flows from operations | -$115.87 | -$203.93 | -$282.33 | -$118.5 |
| Investing activities | ||||
| Capital expenditures | -$0.58 | -$4.47 | -$0.72 | -$0.69 |
| Investments | $140.6 | $116.05 | -$434.72 | $138.1 |
| Total cash flows from investing | $140.01 | $95.13 | -$435.45 | $137.4 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | -$5.07 | -$4.96 | $956.32 | $0.79 |
| Net borrowings | -$30.93 | $1.25 | ||
| Total cash flows from financing | -$33.86 | -$4.96 | $925.39 | $5.84 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$9.72 | -$113.75 | $207.62 | $24.75 |
News
Fundamentals
| Market cap | $1.24B |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 500.29M |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | 0.99 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 1.55 |
| Quick ratio | N/A |